Imricor logo — First & only suite of products for use in the iCMR to levera...

Imricor

First & only suite of products for use in the iCMR to leverage the superior soft tissue imaging capabilities of the MRI.

Founded 2006 United States Burnsville, United States 58 employees Post Ipo Equity Biotechnology, Health Care +1

General Information

Company Name Imricor
Founded Year 2006
Location United States Burnsville, United States +1
Employees 58
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Imricor moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Imricor

Imricor, founded in 2006, aims to revolutionize the electrophysiology field with its innovative suite of products designed for use in the interventional cardiac magnetic resonance (iCMR) lab, making it the first and only of its kind. The company's slogan "First & only suite of products for use in the iCMR to leverage the superior soft tissue imaging capabilities of the MRI" underscores its commitment to leveraging MRI's imaging capabilities to enhance the outcomes and safety of cardiac ablation procedures. Imricor operates in the biotechnology, health care, and pharmaceutical industries. Imricor's pioneering approach has attracted significant attention from investors, with the most recent funding being a Post-IPO Equity investment on 01 October 2023. The details of the last investment, including the amount and the participating investors, were not disclosed. Imricor Medical Systems, Inc. is at the forefront of a promising intersection between cardiology, interventional radiology, and magnetic resonance imaging, presenting an intriguing opportunity for investors seeking to support advancements in the medical technology landscape.

Taxonomy: electrophysiology, cardiac arrhythmias, MRI compatible tools, interventional medical technology, cardiac ablation procedures, MRI imaging, electrophysiology procedures, medical imaging technology

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 01 Oct 2023
Post-IPO Equity •••••• - 21 Feb 2020
Post-IPO Equity •••••• - 11 Sep 2019
Debt Financing •••••• - 24 May 2018
Venture - Series Unknown •••••• - 29 Sep 2017

View All 10 Funding Rounds

Imricor Alternatives & Competitors

Imricor vs
inHEART
inHEART France

inHEART is a spin-off from IHU Liryc and Inria that combines their top-tier expertise in cardiac ele...

11-50 employees
Health Care, Information Technology
Imricor vs
CardioCommand, Inc.
CardioCommand, Inc. United States

It's Right... Next to the Heart

18 employees
Manufacturing
Imricor vs

Largest private practice radiology group in Greater Cincinnati

22 employees
Health Care, Health and Wellness

FAQ About Imricor

First & only suite of products for use in the iCMR to leverage the superior soft tissue imaging capabilities of the MRI.
Imricor was founded in 2006.
Imricor is headquartered in Burnsville, United States.
Imricor operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Imricor has approximately 58 employees.
Imricor has completed 10 funding rounds. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Imricor include inHEART, CardioCommand, Inc., Radiology Associates of Northern Kentucky, CardioInsight Technologies, Imaging Associates. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Imricor and inHEART are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Imricor and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy